oils4cure | Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis

Summary
OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on a medicinal cannabis extract. It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis (YCJ-01) and another for Leukodystrophies (YCJ-02), both are paediatric rare diseases. This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis (TS).
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/190119321
Start date: 01-12-2023
End date: 30-11-2025
Total budget - Public funding: 2 225 538,75 Euro - 1 557 877,00 Euro
Cordis data

Original description

OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on a medicinal cannabis extract. It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis (YCJ-01) and another for Leukodystrophies (YCJ-02), both are paediatric rare diseases. This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis (TS).

Status

SIGNED

Call topic

HORIZON-EIC-2023-ACCELERATOROPEN-01

Update Date

12-03-2024
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
EU-Programme-Call
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2023-ACCELERATOR-01
HORIZON-EIC-2023-ACCELERATOROPEN-01 EIC Accelerator Open 2023